
By Nozithelo T. Moyo, MBBS | Medical Doctor & Health Writer
The word Ebola still carries a unique ability to trigger fear across the world. Few diseases generate the same level of public anxiety, media attention, and international concern in such a short space of time. So when Uganda confirmed cases linked to the current outbreak affecting parts of Central and East Africa, concern spread quickly across the region and beyond.
But amid alarming headlines and growing speculation online, an important question remains: what exactly is Ebola, and how worried should East Africa be right now?
Ebola virus disease (EVD) is a severe viral illness affecting humans and other primates. First identified in 1976 near the Ebola River in what is now the Democratic Republic of the Congo, the disease is caused by viruses in the family Filoviridae. There are six known species of Ebolavirus, but three account for most major outbreaks: Ebola virus (Zaire ebolavirus), Sudan virus, and Bundibugyo virus the strain responsible for the current outbreak.
The current outbreak has been linked to Bundibugyo virus, a rare Ebola-causing pathogen previously documented only twice: in Uganda’s Bundibugyo district in 2007–2008, where 149 cases and 37 deaths were recorded, and in the DRC in 2012, where 57 cases and 29 deaths were reported. This already appears to be the largest documented outbreak of Bundibugyo virus disease.
Unlike the Zaire strain for which effective vaccines and targeted therapeutics exist there are currently no licensed vaccines or approved targeted treatments specifically for Bundibugyo virus disease. This remains one of the most concerning aspects of the current outbreak.
Although Ebola is serious and potentially fatal, it does not spread as easily as airborne illnesses such as COVID-19 or influenza. Ebola spreads through direct contact with the bodily fluids of an infected person including blood, vomit, saliva, sweat, urine, and semen or through contact with contaminated surfaces and materials.
It is not transmitted through the air, which significantly limits its pandemic potential compared with airborne respiratory viruses.
This distinction matters because fear often spreads faster than facts.
Early Ebola symptoms can resemble many common infections, which is part of what makes outbreaks difficult to detect quickly. Symptoms often begin suddenly and may include:
As the disease progresses, some patients develop vomiting, diarrhoea, dehydration, and impaired organ function. Haemorrhagic symptoms visible bleeding are less universal than public perception suggests.
In the original 2007 Bundibugyo outbreak, haemorrhage was reported in only around half of confirmed cases, and most patients presented primarily with gastrointestinal symptoms. Not every patient bleeds visibly; this remains one of the most common public misconceptions about Ebola.
The case fatality rate for Bundibugyo virus disease is estimated at between 25% and 40%, according to Médecins Sans Frontières. This is broadly comparable to Zaire ebolavirus and far higher than most common infectious diseases. Early medical care significantly improves survival.
Preventing Ebola outbreaks relies heavily on rapid public health response. Core measures include:
Healthcare workers depend on strict personal protective equipment protocols to minimise exposure risk.
Treatment for Ebola remains largely supportive. Patients receive intravenous fluids, electrolyte correction, oxygen support, and management of complications while the body mounts an immune response. Early initiation of supportive care significantly improves outcomes.
While monoclonal antibody therapies such as mAb114 and REGN-EB3 have transformed survival rates for Zaire ebolavirus infections, there are currently no vaccines in late-stage clinical development that could be readily deployed during this outbreak. As a result, response efforts rely heavily on classical public health control measures and supportive clinical care.
On 5 May 2026, the World Health Organization (WHO) was alerted to a high-mortality outbreak of unknown illness in Mongbwalu Health Zone, Ituri Province, DRC, including deaths among healthcare workers. On 14 May, laboratory analysis confirmed Bundibugyo virus disease in eight of thirteen blood samples collected from Rwampara Health Zone.
On 15 May, Uganda’s Ministry of Health confirmed an outbreak following the identification of an imported case a Congolese national who later died in Kampala. A second confirmed case in Kampala was identified the following day.
These two cases, appearing within 24 hours of each other and with no apparent epidemiological link, became a major factor in triggering the international emergency response.
On 16 May 2026, the WHO Director-General determined that the outbreak constituted a Public Health Emergency of International Concern (PHEIC) the organisation’s highest level of alert under international health regulations though it does not meet the criteria of a pandemic emergency.
Notably, this marked the first time a PHEIC was declared without first convening an emergency committee, reflecting the speed and seriousness with which the situation evolved.
Health authorities are particularly concerned because:
Concern is appropriate. Panic is not.
The WHO has advised against countries outside the immediate region imposing travel or trade restrictions, and the PHEIC declaration reflects operational complexity and the need for coordinated international support rather than evidence of high global risk to the general public.
Uganda is not entering this situation without experience. The country has managed multiple Ebola outbreaks since its first major outbreak in Gulu in 2000 and has since developed surveillance systems, infection prevention protocols, laboratory capacity, and cross-border coordination mechanisms.
The confirmed Kampala cases are currently being managed under appropriate containment protocols, with contact tracing efforts already underway.
What happens next will depend largely on:
Outbreaks are rarely defined by the virus alone. They are shaped by healthcare systems, political coordination, public trust, and how quickly communities and institutions respond under pressure.
Understanding Ebola matters just as much as fearing it.